Integer Holdings Corporation (ITGR)

Market Cap	2.26B
Revenue (ttm)	1.83B
Net Income (ttm)	86.90M
Shares Out	35.04M
EPS (ttm)	2.42
PE Ratio	26.54
Forward PE	10.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,617,863
Open	63.93
Previous Close	63.32
Day's Range	62.10 - 64.88
52-Week Range	62.00 - 146.36
Beta	0.97
Analysts	Buy
Price Target	94.29 (+46.03%)
Earnings Date	Oct 23, 2025

About ITGR

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable c...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 29, 2000
• Employees: 11,000
• Stock Exchange: NYSE
• Ticker Symbol: ITGR
• Website: https://www.integer.net

Financial Performance

In 2024, Integer Holdings's revenue was $1.72 billion, an increase of 10.35% compared to the previous year's $1.56 billion. Earnings were $119.90 million, an increase of 32.26%.

Analyst Summary

According to 8 analysts, the average rating for ITGR stock is "Buy." The 12-month stock price target is $94.29, which is an increase of 46.03% from the latest price.

Price Target

$94.29

(46.03% upside)

Analyst Consensus: Buy